Bank of New York Mellon’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
CIAM
AAP
QC
DJYG
SOW
FCG
MMA
Bank of New York Mellon's STIM Position: Q2 2026 in Review
Bank of New York Mellon sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 78,605 shares — an estimated $114K sold.
Bank of New York Mellon first reported a position in STIM in Q3 2018 and held it in 28 quarters. The position peaked at $1.72M in Q2 2021. 24 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- Bank of New York Mellon reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
- Bank of New York Mellon sold 78,605 Neuronetics shares in Q2 2026, an estimated $114K.
- Bank of New York Mellon first reported a position in Neuronetics in Q3 2018 and held it in 28 quarters.
- Bank of New York Mellon's Neuronetics position peaked at $1.72M in Q2 2021.
- 24 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.